Cell and Gene Commercialization

  1. Navigating The Challenges Of Bringing Cell And Gene Therapies To Market 7/24/2024

    Cell and gene therapies are witnessing rapid advancements, but significant challenges remain for their commercialization due to regulatory hurdles, manufacturing barriers, high costs, and safety concerns.

  2. Help Bring Your Breakthrough Cancer Treatments To Market Faster 7/18/2024

    Let us expedite the journey of your treatment from the research phase to the patient, ensuring that life-saving therapies reach those in need as swiftly as possible.

  3. Wherever You're Going, Our Regulatory And Access Experts Have Been There 7/18/2024

    With our consulting team by your side, comprised of over 1,000 dedicated professionals, you can be confident that your treatment’s journey from research to patient care is in expert hands.

  4. Maintain Control Over Your Regulatory Path And Mitigate Risks 7/18/2024

    Our expertise spans the entire drug development process, navigating challenges posed by globalization, stakeholder engagement, scientific innovation, and payer expectations.

  5. Insights into Global Non-Small Cell Lung Cancer Research 7/3/2024

    This FAQ section delves into non-small cell lung cancer (NSCLC) incidence, current trials, innovative drugs, and their effects on patient outcomes.

  6. Radiopharmaceutical Therapy: Global Clinical Trial Insights 2024 7/3/2024

    By downloading this report, readers will uncover the transformative potential of radiopharmaceuticals in cancer therapy and stay ahead in the evolving cancer treatment landscape.

  7. Non-Small Cell Lung Cancer — Global Clinical Trial Landscape (2024) 7/3/2024

    Explore cutting-edge Non-Small Cell Lung Cancer (NSCLC) research with Novotech CRO's in-depth disease analysis, providing insights into innovative therapies, clinical trials, and future directions shaping NSCLC care globally.

  8. Liver Cancer — Global Clinical Trial Landscape (2024) 7/3/2024

    Explore the latest advancements and clinical trial landscape in liver cancer research with Novotech CRO's comprehensive disease report.

  9. The Current State Of Cell Therapy Manufacturing 7/3/2024

    Expert panelists on Cell & Gene Live, Inside Next-Gen Platforms for Cell Therapy Manufacturing, share their points of view on cell therapy manufacturing as it stands today.

  10. Inside Next-Gen Platforms For Cell Therapy Manufacturing 6/28/2024

    With additional cell therapy approvals on the horizon, diverse products and platforms are needed to help ensure safety and efficacy in manufacturing, increase speed to market, and decrease overall CoGS.